Elimination of a genetic correlation between the sexes via artificial correlational selection LF Delph, JC Steven, IA Anderson, CR Herlihy, ED Brodie III Evolution 65 (10), 2872-2880, 2011 | 86 | 2011 |
Beyond histology: translating tumor genotypes into clinically effective targeted therapies CB Meador, CM Micheel, MA Levy, CM Lovly, L Horn, JL Warner, ... Clinical Cancer Research 20 (9), 2264-2275, 2014 | 78 | 2014 |
Relaxed pollinator‐mediated selection weakens floral integration in self‐compatible taxa of Leavenworthia (Brassicaceae) IA Anderson, JW Busch American Journal of Botany 93 (6), 860-867, 2006 | 63 | 2006 |
The path (way) less traveled: a pathway-oriented approach to providing information about precision cancer medicine on my cancer genome AD Taylor, CM Micheel, IA Anderson, MA Levy, CM Lovly Translational oncology 9 (2), 163-165, 2016 | 32 | 2016 |
Guiding oncology patients through the maze of precision medicine NB Giuse, SV Kusnoor, TY Koonce, HM Naylor, SC Chen, ... Journal of health communication 21 (sup1), 5-17, 2016 | 32 | 2016 |
My cancer genome: evaluating an educational model to introduce patients and caregivers to precision medicine information SV Kusnoor, TY Koonce, MA Levy, CM Lovly, HM Naylor, IA Anderson, ... AMIA Summits on Translational Science Proceedings 2016, 112, 2016 | 28 | 2016 |
Internet-based assessment of oncology health care professional learning style and optimization of materials for web-based learning: controlled trial with concealed allocation CM Micheel, IA Anderson, P Lee, SC Chen, K Justiss, NB Giuse, F Ye, ... Journal of medical Internet research 19 (7), e265, 2017 | 16 | 2017 |
My cancer genome: coevolution of precision oncology and a molecular oncology knowledgebase ME Holt, KF Mittendorf, M LeNoue-Newton, NM Jain, I Anderson, ... JCO Clinical Cancer Informatics 5, 995-1004, 2021 | 14 | 2021 |
Preliminary results from a phase II study of the combination of pevonedistat and azacitidine in the treatment of MDS and MDS/MPN after failure of DNA methyltransferase inhibition TK Moyo, JM Watts, BS Skikne, JH Mendler, VM Klimek, SC Chen, R Fan, ... Blood 134, 4236, 2019 | 12 | 2019 |
PI3K inhibition restores and amplifies response to ruxolitinib in patients with myelofibrosis TK Moyo, A Kishtagari, MT Villaume, B McMahon, SR Mohan, ... Clinical Cancer Research 29 (13), 2375-2384, 2023 | 3 | 2023 |
Rapid reversal of a potentially constraining genetic covariance between leaf and flower traits in Silene latifolia JC Steven, IA Anderson, ED Brodie III, LF Delph Ecology and Evolution 10 (1), 569-578, 2020 | 3 | 2020 |
Topic: AS08-Treatment/AS08f-Clinical trials–Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT … J Watts, B Smith, T Bradley, B Skikne, J Mendler, V Klimek, A Thomassen, ... Leukemia Research 128, 107272, 2023 | | 2023 |
11. MCG 2.0: A highly curated, scalable precision cancer medicine resource M Holt, C Micheel, I Anderson, M LeNoue-Newton, N Jain, C Miller, ... Cancer Genetics 233, S5, 2019 | | 2019 |
49. Assessment of breast cancer trial landscape utilizing a structured clinical trial knowledgebase N Jain, M LeNoue-Newton, I Anderson, C Micheel, M Levy Cancer Genetics 226, 54, 2018 | | 2018 |
27. Biomarker driven clinical trial curation and search M LeNoue-Newton, N Jain, I Anderson, C Micheel, M Levy Cancer Genetics 226, 46, 2018 | | 2018 |
7. Data and knowledge sharing to improve patient care: The VICC and MCG experience I Anderson, N Jain, M LeNoue-Newton, C Micheel, M Levy Cancer Genetics 226, 38-39, 2018 | | 2018 |
The role of developmental constraint in mating-system evolution in Leavenworthia: A quantitative genetic analysis IA Anderson Indiana University, 2005 | | 2005 |